Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1111JC101----1件: 25 💬
2CE-VST01-JC1件: CE-VST01-JC---1件: 25 💬
3Cidofovir1件: Cidofovir1件: Cidofovir 💬--1件: 25 💬
4Collection of blood and urine----1件: 25 💬
5CYT107----1件: 25 💬
6Cytarabine1件: Cytarabine1件: Cytarabine 💬--7件: 11, 13, 14, 25, 49, 60, 65 💬
7Didanosine1件: Didanosine1件: Didanosine 💬--2件: 25, 265 💬
8Emtricitabine1件: Emtricitabine1件: Emtricitabine 💬--4件: 25, 93, 265, 325 💬
9Enfuvirtide1件: Enfuvirtide1件: Enfuvirtide 💬--2件: 25, 265 💬
10Filgrastim1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬28件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
11Interferon alfa1件: Interferon alfa1件: Interferon alfa 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬5件: 25, 26, 28, 56, 96 💬
12Interferon alfa-2b2件: Interferon alfa,
Interferon alfa-2b		2件: Interferon alfa-2b ,
Interferon alfa 💬		2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 25 💬
13Interleukin-71件: Interleukin-7---1件: 25 💬
14Lariam1件: Mefloquine1件: Mefloquine 💬--1件: 25 💬
15MEFLOQUINE1件: Mefloquine1件: Mefloquine 💬--2件: 25, 46 💬
16Methylprednisolone1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
17NATALIZUMAB1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬5件: 13, 15, 25, 46, 96 💬
18Neurological evaluation----1件: 25 💬
19NT-I71件: Efineptakin alfa1件: Efineptakin alfa 💬--1件: 25 💬
20Pembrolizumab1件: Pembrolizumab1件: Pembrolizumab 💬1件: PDCD1 💬3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬2件: 25, 285 💬
21PREDNISOLONE1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
22Probenecid1件: Probenecid1件: Probenecid 💬--1件: 25 💬
23PyVST----1件: 25 💬
24Recombinant human interleukin-71件: Interleukin-7---1件: 25 💬
25Spinal tap----1件: 25 💬
26Tenofovir2件: Tenofovir,
Tenofovir disoproxil		1件: Tenofovir 💬--6件: 2, 13, 25, 93, 265, 325 💬
27Tenofovir-Emtricitabine2件: Emtricitabine,
Tenofovir		2件: Emtricitabine ,
Tenofovir 💬		--1件: 25 💬
28TERIFLUNOMIDE1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬3件: 13, 25, 26 💬
29Topotecan1件: Topotecan1件: Topotecan 💬1件: TOP1 💬-1件: 25 💬
30TYSABRI1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬3件: 13, 25, 63 💬
31Zalcitabine1件: Zalcitabine1件: Zalcitabine 💬--1件: 25 💬
32Zidovudine1件: Zidovudine1件: Zidovudine 💬--6件: 25, 26, 135, 265, 325, 331 💬